Neuroscience
Parkinson's Disease
100%
Parkinsonism
25%
L-DOPA
24%
Dyskinesia
23%
Ketamine
23%
Familial Parkinson's Disease
18%
Potassium Channel
18%
Virus Vector
18%
Dopamine Transporter
18%
In Vitro
16%
Neuroprotective Agent
16%
Dopaminergic
15%
Single-Photon Emission Computed Tomography
15%
Anesthetics
15%
Decision-Making
14%
Vasculotropin B
13%
Ioflupane (123I)
13%
Basal Ganglia
12%
Electrical Brain Stimulation
12%
Green Fluorescent Protein
11%
Subthalamic Nucleus
11%
Sodium Channel
10%
Herpes
10%
Striatum
10%
Stereotypic Movement Disorder
9%
Skeletal Muscle
9%
In Vivo
9%
Opiate
9%
Tetrodotoxin
9%
Glycopeptide
9%
Pigment Epithelium Derived Factor
9%
Neurite
9%
Vascular Endothelial Growth Factor
9%
Behavior (Neuroscience)
9%
Putamen
8%
Excitability
8%
Attention Deficit Hyperactivity Disorder
8%
Kv1.1
7%
Gene Expression
7%
Neurite Outgrowth
6%
Saxitoxin
6%
Visual Pigment
6%
Treatment of Parkinson's Disease
6%
Hippocampus
6%
Agonist
6%
Voltage Clamp
6%
Epithelial Cells
6%
Dopaminergic Neuron
5%
Huntington's Disease
5%
Fusion Protein
5%
Keyphrases
Parkinson's Disease
65%
Levodopa-induced Dyskinesia
16%
Vascular Endothelial Growth Factor B
13%
Parkinson's Disease Model
13%
L-DOPA
12%
Parkinson Patients
12%
Rodent Models
9%
Dopaminergic Neurons
9%
Intravenous Ketamine
9%
Neuroprotective
9%
Older Adults
9%
123I-IMP
9%
Pigment Epithelium-derived Factor
9%
Dopamine Transporter Imaging
9%
Parkinsonian Syndromes
8%
Electroacupuncture
7%
Abnormal Involuntary Movements
7%
Vascular Endothelial Growth Factor
6%
Retinal pigment Epithelium
6%
Parkinsonism
5%
6-hydroxydopamine (6-OHDA)
5%
Glycopeptides
5%
In Vitro Model
5%
Subthalamic nucleus Deep Brain Stimulation (STN-DBS)
5%
Age of Onset
5%
Dyskinetic
5%
Deep Brain Stimulation
5%
Fall Risk
5%
Brain Imaging
5%
Idiopathic Parkinson's Disease
5%
Ketamine Treatment
5%
Dopamine Depletion
5%
Neurotrophic Factors
5%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson's Disease
30%
Levodopa-Induced Dyskinesia
27%
Ketamine
13%
DOPA
13%
Glycopeptide
10%
Sodium Channel
9%
Ioflupane (123I)
9%
Tetrodotoxin
9%
Visual Pigment
9%
Pigment Epithelium Derived Factor
9%
Saxitoxin
6%
Dyskinesia
6%
Opiate Peptide
5%
Opiate
5%
Disease
5%
Opiate Agonist
5%
Dopamine Receptor Stimulating Agent
5%
Neurotrophic Factor
5%
